TRAUMAGEL Study Shows Hemorrhage Control Holds Without Rebleeding After Tourniquet Removal

A clinical study examining a gel-based hemorrhage control product found that it provided sustained bleeding control and allowed for tourniquet removal without rebleeding, according to Yahoo Finance Singapore. The study, identified as the TRAUMAGEL study, focused on traumatic wounds where controlling blood loss quickly is a critical factor in patient survival.

Tourniquets are a standard tool in trauma care for stopping severe limb bleeding, but they carry their own risks when left in place for extended periods, including tissue damage. A product that could maintain hemorrhage control and allow earlier tourniquet removal would address one of the persistent challenges in both battlefield and emergency trauma care.

The TRAUMAGEL study data showed that the gel held bleeding at bay after the tourniquet was taken off, with no rebleeding reported in the cases examined. The report did not specify the full size of the study population or the settings in which the cases were collected.

Hemorrhage remains one of the leading causes of preventable death in trauma patients. Research into improved materials for wound packing and bleeding control has been a consistent area of focus in military medicine and emergency trauma care over the past two decades.

Further details on the study's methodology and patient outcomes were not released in the initial report. No regulatory submissions or timelines for broader clinical use were mentioned.